Pfizer to raise US drug prices in January after previously backing down under Trump pressure Medical Dialogues Bureau19 Nov 2018 1:14 PM ISTNEW YORK: Pfizer Inc has recently announced that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous...
Pfizer Q2 net profit falls 14% to Rs 95.8 crore Medical Dialogues Bureau18 Nov 2018 9:00 AM ISTNew Delhi: Drug firm Pfizer has recently reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September...
Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court Medical Dialogues Bureau15 Nov 2018 11:42 AM ISTThe expiry of the basic patent on Lyrica five years ago had allowed generic drugmakers to launch cut-price versions of Pfizer's medicine, which...
FDA approves Pfizer's Lorbrena treatment for certain lung cancer patients Medical Dialogues Bureau7 Nov 2018 9:40 AM ISTLorbrena, known chemically as lorlatinib, received an accelerated approval, Pfizer said. Its continued approval may depend on verification of clinical...
Pfizer lowers revenue forecast on strong dollar, supply issues Medical Dialogues Bureau31 Oct 2018 5:15 PM ISTU.S. drugmaker Pfizer Inc cut the top end of its full-year revenue forecast range on Tuesday, citing a stronger dollar and lower revenue from its...
Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs Ruby Khatun Khatun8 Sept 2018 6:13 PM ISTThe 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D-Cold Tablet, Alkem's Sumo, Franco-Indian...
Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer Ruby Khatun Khatun3 Sept 2018 10:30 AM ISTMumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new...
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby Khatun Khatun31 Aug 2018 4:50 PM ISTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
Reckitt Benckiser pulls out of Pfizer consumer health auction Ruby Khatun Khatun23 March 2018 10:00 AM ISTBritish consumer goods maker Reckitt Benckiser Group said it had ended discussions with Pfizer Inc over buying its consumer healthcare business, a day...
Brands in India to be included in review for consumer health business: Pfizer Ruby Khatun Khatun6 March 2018 9:45 AM ISTNew Delhi: Drug firm Pfizer said Gelusil, Becosules and Corex brands in India will be included in the global strategic review of the consumer...
Merck's consumer health sale at risk as Nestle bows out, says report Ruby Khatun Khatun6 Feb 2018 9:45 AM ISTThe sale of Merck KGaA's consumer health unit has been thrown off track after Nestle has pulled out, leaving the race to buy the maker of Seven Seas...
Pfizer gets USFDA approval for second biosimilar of Remicade Ruby Khatun Khatun18 Dec 2017 10:15 AM ISTThe U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
